Kobapeg-N Tablet is a combination medication containing Pregabalin 75 mg, Nortriptyline 10 mg, and Methylcobalamin 1500 mcg, formulated for the management of neuropathic pain and related neurological disorders. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, acts by modulating calcium channels in the central nervous system, thereby reducing neuronal excitability and alleviating neuropathic pain symptoms. Nortriptyline, a tricyclic antidepressant, contributes analgesic effects through the inhibition of norepinephrine and serotonin reuptake, enhancing descending inhibitory pain pathways. Methylcobalamin, an active form of vitamin B12, supports nerve regeneration and repair, promoting improved nerve function and reducing neuropathy progression. The synergistic action of these components makes Kobapeg-N effective in treating diabetic neuropathy, postherpetic neuralgia, and other peripheral neuropathies. It is recommended to be taken under medical supervision, with dosage adjustments based on patient response and tolerability. Common side effects may include dizziness, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with renal impairment, cardiovascular conditions, or those taking other central nervous system depressants. Kobapeg-N Tablet should not be used during pregnancy or lactation unless clearly indicated by a healthcare professional.